These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 4632587

  • 21. Drugs of abuse and experimental autoimmune diseases.
    Lyman WD.
    Adv Exp Med Biol; 1991; 288():81-92. PubMed ID: 1659140
    [No Abstract] [Full Text] [Related]

  • 22. The relation of experimental allergic encephalitis to multiple sclerosis.
    Campbell B, Vogel PJ.
    Trans Am Neurol Assoc; 1967; 92():150-2. PubMed ID: 5634013
    [No Abstract] [Full Text] [Related]

  • 23. [Multiple sclerosis: from immunopathogenesis to disease management].
    Nervenarzt; 1996 Dec; 67(12 Suppl Von Der Im):1-8. PubMed ID: 9403091
    [No Abstract] [Full Text] [Related]

  • 24. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Reichardt HM, Gold R, Lühder F.
    Expert Rev Neurother; 2006 Nov; 6(11):1657-70. PubMed ID: 17144780
    [Abstract] [Full Text] [Related]

  • 25. [Various aspects of immunopathogenesis of multiple sclerosis and therapeutic possibilities].
    Aleksandrowicz J, Blicharski J, Skotnicki A, Retinger M, Zduńczyk A.
    Pol Tyg Lek; 1981 Aug 31; 36(35):1363-5. PubMed ID: 7036112
    [No Abstract] [Full Text] [Related]

  • 26. Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.
    Chitnis T, Khoury SJ.
    J Allergy Clin Immunol; 2003 Nov 31; 112(5):837-49; quiz 850. PubMed ID: 14610467
    [Abstract] [Full Text] [Related]

  • 27. Targeting monocyte recruitment in CNS autoimmune disease.
    Izikson L, Klein RS, Luster AD, Weiner HL.
    Clin Immunol; 2002 May 31; 103(2):125-31. PubMed ID: 12027417
    [Abstract] [Full Text] [Related]

  • 28. Immune-based therapy of multiple sclerosis.
    Kaufman MD.
    N C Med J; 1995 Aug 31; 56(8):379-84. PubMed ID: 7566191
    [No Abstract] [Full Text] [Related]

  • 29. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
    Lukinović-Skudar V, Taradi SK, Andreis I, Zupancić V, Taradi M.
    Lijec Vjesn; 2001 Aug 31; 123(3-4):81-8. PubMed ID: 11488222
    [Abstract] [Full Text] [Related]

  • 30. [Immunosuppressive therapy and humoral immunity in multiple sclerosis].
    Mavra M.
    Srp Arh Celok Lek; 1980 Nov 31; 108(11):1139-48. PubMed ID: 7313825
    [No Abstract] [Full Text] [Related]

  • 31. [The nature of the demyelinating process in clinical and experimental neurology].
    Markov DA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969 Nov 31; 69(7):967-75. PubMed ID: 5368925
    [No Abstract] [Full Text] [Related]

  • 32. [Multiple sclerosis].
    Steck AJ.
    Rev Med Suisse Romande; 1984 Mar 31; 104(3):231-8. PubMed ID: 6326241
    [No Abstract] [Full Text] [Related]

  • 33. Immunology of multiple sclerosis.
    Kibler RF, Paty DW, Sherr V.
    Res Publ Assoc Res Nerv Ment Dis; 1971 Mar 31; 49():95-111. PubMed ID: 5133707
    [No Abstract] [Full Text] [Related]

  • 34. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease.
    Weiner HL.
    Arch Neurol; 2004 Oct 31; 61(10):1613-5. PubMed ID: 15477521
    [No Abstract] [Full Text] [Related]

  • 35. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite.
    Platten M, Ho PP, Youssef S, Fontoura P, Garren H, Hur EM, Gupta R, Lee LY, Kidd BA, Robinson WH, Sobel RA, Selley ML, Steinman L.
    Science; 2005 Nov 04; 310(5749):850-5. PubMed ID: 16272121
    [Abstract] [Full Text] [Related]

  • 36. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis.
    Massacesi L, Genain CP, Lee-Parritz D, Letvin NL, Canfield D, Hauser SL.
    Ann Neurol; 1995 Apr 04; 37(4):519-30. PubMed ID: 7717689
    [Abstract] [Full Text] [Related]

  • 37. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
    Raine CS.
    Lab Invest; 1984 Jun 04; 50(6):608-35. PubMed ID: 6202955
    [No Abstract] [Full Text] [Related]

  • 38. Significance of autoreactive T cells in diseases such as multiple sclerosis using an innovative primate model.
    McFarland HF.
    J Clin Invest; 1994 Sep 04; 94(3):921-2. PubMed ID: 8083376
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.